Skip to content

Aerofit Post Market Investigation

Evaluation of the Clinical Benefits of a Ventilating Suspension Interface for Individuals With Transfemoral Amputation, a Randomized Controlled Cross-over Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05925712
Enrollment
56
Registered
2023-06-29
Start date
2023-06-06
Completion date
2024-05-31
Last updated
2024-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation, Skin Health, Transfemoral Amputation

Brief summary

The goal of this clinical investigation is to evaluate the clinical benefits of a ventilating suspension interface for individuals with transfemoral amputation. The main aim of the investigation will be to evaluate the clinical user-reported benefits to skin health from using a ventilating lower limb prosthetic suspension system and compare it to a non-ventilating suspension system.

Interventions

DEVICEAeroFit Seal-In Liner / Socket

Össur AeroFit® solution is a transfemoral breathable prosthetic interface, combining the AeroFit® Seal-In liner and AeroFit® Socket.

DEVICESeal-In Silicone Liner

Seal-In Silicone Lineris transfemoral prosthetic interface used in combination with a prosthetic socket system.

Sponsors

Össur Iceland ehf
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 50Kg\< body weight \< 136Kg * Cognitive ability to understand all instructions and questionnaires in the study * Intended for unilateral/bilateral individuals that fit the indications for use, fit within the specified criteria and with the limb length, shape and ability to use a prosthetic liner: Activity level: K1 - K4, Impact level: Low to high, Amputation level: transfemoral * Congenital transverse deficiency at femoral level * Using Seal-In Silicone Liner and Direct Socket or AeroFit Seal-In Liner and AeroFit Socket * Able to use AeroFit Solution, see Figure 7 AeroFit Seal-In Liner Sizes and Figure 8 Minimum socket height per liner profile. * Residual limb profile: Standard or conical * Willing and able to participate in the study and follow the protocol * Confident (all day) prosthetic users for more than 3 months * Older than 18 years

Exclusion criteria

* Participating in another research study that may affect the participation or results of this study (in the opinion of the investigator) * Users that have received Botox injection as treatment for residual limb sweat issue in the last 4 months

Design outcomes

Primary

MeasureTime frameDescription
Subject perceived skin health (PEQ-RLH)4 weeksPEQ-RLH (Prosthesis Evaluation Questionnaire - Residual Limb Health) Questionnaire Mean of six 1-10 point scale items, higher score indicates better RLH

Secondary

MeasureTime frameDescription
Subject perceived activity restriction and prosthesis use, TAPES-R4 weeksSelf-report: TAPES-R (Trinity Amputation and Prosthesis Experiences Scales) - Activity Restriction scale Mean of ten 3-point scale items, higher score indicates less restriction
Subject perceived quality of life EQ-5D-5L4 weeksSelf-report: EQ-5D-5L 5-level EQ-5D version (EQ-5D-5L) Use of AeroFit system provides non-inferior quality of life\* 0-1.00 index value, higher value indicates higher QALY
Incidents of prosthesis slippage, the need to remove liner to dry limb or liner and incidents of complete loss of suspension.4 weeksSelf-report: In-house generated questionnaire on prosthesis slippage and the need to remove prosthesis due to moisture . Higher score means worse slippage experience.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026